IESE (España)
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
Spainoil
Agustín, Antonio; Nueno, José LuisCase M-1067MarketingDescribe las variables y puesta en marcha de un programa de gestión por categorias.Starting at €8.20
-
New Immuno-Oncology Solutions (NIOS) - Teaching Note: Aligning stakeholders in the biotech industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacTeaching Note SMT-136-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €0.00
-
Cafés Ferrachat
Agustín, Antonio; Farrero, E.; Nueno, José LuisCase M-993-EMarketingStarting at €8.20
-
Cafés Ferrachat
Agustín, Antonio; Farrero, E.; Nueno, José LuisCase M-993MarketingCafés Ferrachat es una compañía con una buena posición en el mercado francés: 25% de participación de mercado y una marca de reconocido prestigio, Philtre d'or. Jacques Ferrachat recibe de su director comercial la propuesta de servir a la distribución un volumen importante de café en marca privada y duda de que el incremento de ventas compense la inversión en producción y la imagen de «mental lidership» de su compañía.Starting at €8.20